Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06416306 · ClinicalTrials.gov registry record · Phase 1
Treatment Targets in Spanish and English Bilingual Speech Intervention
A Phase 1 study of Speech Sound Disorder, sponsored by Philip Combiths.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06416306: Recruiting Phase 1 study of Speech Sound Disorder, sponsored by Philip Combiths.
NCT06416306 is a Phase 1 study of Speech Sound Disorder that is actively recruiting participants, run by Philip Combiths. The registered enrollment target is 16 participants, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06416306, a Phase 1 study of Speech Sound Disorder, is actively recruiting participants, sponsored by Philip Combiths.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn which speech treatment targets result in the greatest amount of speech learning in Spanish-English bilingual children with speech sound disorders. The main questions it aims to answer are: * Does linguistic complexity of the treatment target increase the amount of generalized learning within the treated language? * Does linguistic complexity of the treatment target increase the amount of generalized speech across languages? Researchers will compare intervention effects across treatment provided in English and Spanish to see if the effect differs according to the language of intervention. Participants will: * Attend between 12 and 18 45-minute speech intervention sessions in Spanish or English for up to 6 weeks * Attend assessment visits before and after intervention * Attend follow-up assessment visits 1 month and 2 months after intervention
Primary Outcome
Accuracy data for the dependent variable will be derived from narrow phonetic transcription of participants' productions from speech generalization probes in English and Spanish. Both protocols elicit \~300 word productions and sample each singleton consonant and consonant cluster in the respective language a minimum of three times in every permissible word position. The entire generalization probe is administered at each assessment visit (Pre, Post, and 1- and 2-Month Follow-Ups), and shorter s
Conditions Studied
Interventions
- BEHAVIORAL Speech Intervention
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 1 |
What NCT06416306 shows while recruiting
NCT06416306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 1 intervention - of which Speech Intervention is the first listed.
NCT06416306 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06416306 about?
NCT06416306 is a clinical study titled "Treatment Targets in Spanish and English Bilingual Speech Intervention". The goal of this clinical trial is to learn which speech treatment targets result in the greatest amount of speech learning in Spanish-English bilingual children with speech sound disorders. The main questions it aims to answer are: * Does linguistic complexity of the treatment target increase the ...
What is the current status of trial NCT06416306?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2024-05-08. Estimated completion is 2027-03-31.
What conditions does trial NCT06416306 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT06416306?
The interventions under investigation include: Speech Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06416306?
This trial is sponsored by Philip Combiths, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06416306 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06416306's enrollment target sits among peer trials
16 15th of 15 higher than 1 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
RECRUITING · Phase 1
-
Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
RECRUITING
-
Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial
RECRUITING · Phase 2
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Generalization With AI Navigation Using StaRt
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI